Mail

UK markets closed

FTSE 100
8,213.49
+41.34(+0.51%)
FTSE 250
20,164.54
+112.21(+0.56%)
AIM
771.53
+3.42(+0.45%)
GBP/EUR
1.1652
-0.0031(-0.26%)
GBP/USD
1.2546
+0.0013(+0.11%)
Bitcoin GBP
50,314.64
+3,152.10(+6.68%)

Best savings accounts that offer above inflation rates

Where to find a top-rated deal that works for you

Arbutus Biopharma Corporation (0SGC.L)

LSE - LSE Delayed price. Currency in USD

Add to watchlist

2.7400

+0.0180

(+0.66%)

At close: 07:02PM BST

Insider roster

Insider transactions

Insider roster

Individual or entity	Most-recent transaction	Date	Shares owned as of transaction date
ABRAMS MICHAEL J Officer	Conversion of Exercise of derivative security	16 Aug 2016	42,097
COLLIER WILLIAM H. Chief Executive Officer	Stock Award(Grant)	01 Feb 2023	216,500
HASTINGS DAVID C Chief Financial Officer	Sale	02 Feb 2024	181,907
HOWARD ELIZABETH ANN Officer	Stock Award(Grant)	01 Feb 2023	86,024
MC ELHAUGH MICHAEL JOHN Chief Executive Officer	Sale	02 Feb 2024	1,504,790
MURRAY MARK J Director	Conversion of Exercise of derivative security	28 Nov 2018	341,396
NAFTZGER J CHRISTOPHER General Counsel	Stock Award(Grant)	01 Feb 2024	95,100
ROIVANT SCIENCES LTD. Beneficial Owner of more than 10% of a Class of Security	Conversion of Exercise of derivative security	18 Oct 2021	38,847,500
SIMS KAREN Officer	Sale	02 Feb 2024	125,542
SOFIA MICHAEL JOSEPH Officer	Sale	02 Feb 2024	1,652,280
*Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.